Table 1 |
||||
|
Distribution of the various phenotypic variables in males and females. |
||||
| DESCRIPTIVES |
MALES (N = 243) |
FEMALES (N = 44) |
||
|
|
||||
| (%) |
Mean ± SD |
(%) |
Mean ± SD |
|
|
|
||||
| Age at recruitment |
57.2 ± 8.7 |
57.82 ± 7.59 |
||
| Body Mass Index (kg/m2) |
25.63 ± 3.8 |
28.38 ± 5.4 |
||
| Waist-Hip-Ratio |
0.96 ± 0.05 |
0.87 ± 0.09 |
||
| Diabetes |
44.9 |
67.4 |
||
| Hypertension |
48.2 |
72.1 |
||
| Smoking |
47.3 |
- |
||
| Total cholesterol |
156.73 ± 39.3 |
166.23 ± 36.72 |
||
| Triglycerides |
149.39 ± 75.3 |
150.59 ± 52.02 |
||
| High Density lipoprotein |
37.86 ± 9.49 |
39.91 ± 8.75 |
||
| Low Density Lipoprotein |
88.88 ± 33.29 |
96.17 ± 35.43 |
||
| Apolipoprotein A1 |
1.12 ± 0.24 |
1.18 ± 0.18 |
||
| Apolipoprotein B100 |
0.92 ± 0.26 |
0.93 ± 0.20 |
||
| Age at onset of CAD |
51.34 ± 8.6 |
53.64 ± 7.8 |
||
| Event score |
||||
| 1 (Mild) |
3.9 |
4.8 |
||
| 2 (Moderate) |
27.6 |
28.6 |
||
| 3 (Severe) |
68.4 |
66.7 |
||
| No. of disease vessels |
||||
| 1 |
16.9 |
23.3 |
||
| 2 |
21.9 |
30.0 |
||
| ≥ 3 |
61.2 |
46.4 |
||
| Statin therapy |
62.6 |
78.3 |
||
| Beta blockers |
55.7 |
69.6 |
||
| ACE inhibitors |
32.8 |
41.3 |
||
| Calcium Channel blockers |
37.3 |
23.9 |
||
| Hypoglycemic agents |
32.8 |
36.9 |
||
|
CAD, coronary artery disease. | ||||
Shanker et al. Lipids in Health and Disease 2008 7:33 doi:10.1186/1476-511X-7-33 |
||||
